fucidin 20 mg/g mazilo
leo pharma a/s - natrijev fusidat - mazilo - natrijev fusidat 20 mg / 1 g - fusidna kislina
daivobet 50 mikrogramov/500 mikrogramov v 1 g mazilo
leo pharma a/s - betametazon; kalcipotriol - mazilo - betametazon 50 µg / 1 g kalcipotriol50 µg / 1 g; kalcipotriol 50 µg / 1 g - kalcipotriol, kombinacije
daivobet 50 mikrogramov/500 mikrogramov v 1 g mazilo
leo pharma a/s - betametazon; kalcipotriol - mazilo - betametazon 50 µg / 1 g kalcipotriol50 µg / 1 g; kalcipotriol 50 µg / 1 g - kalcipotriol, kombinacije
locoidon crelo 1 mg/g dermalna emulzija
leo pharma a/s - hidrokortizonbutirat - dermalna emulzija - hidrokortizonbutirat 1 mg / 1 ml - hidrokortizonbutirat
locoidon lipocrema 1 mg/g krema
leo pharma a/s - hidrokortizonbutirat - krema - hidrokortizonbutirat 1 mg / 1 ml - hidrokortizonbutirat
xamiol 50 mikrogramov/500 mikrogramov v 1 g gel
leo pharma a/s - betametazon; kalcipotriol - gel - betametazon 500 µg / 1 g kalcipotriol50 µg / 1 g; kalcipotriol 50 µg / 1 g - kalcipotriol, kombinacije
protopic
leo pharma a/s - takrolimus - dermatitis, atopic - drugi dermatološki preparati - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. nastale štiri ali večkrat na leto), ki so imeli začetni odziv na največ šest tednov, zdravljenje dvakrat na dan tacrolimus mazilo (lezije, izbrisani, skoraj izbrisani, ali lahko vpliva).
kyntheum
leo pharma a/s - brodalumab - psoriaza - imunosupresivi - kyntheum je indiciran za zdravljenje zmerne do hude psoriaze v plakih pri odraslih bolnikih, ki so kandidati za sistemsko zdravljenje.
adtralza
leo pharma a/s - tralokinumab - dermatitis, atopic - drugi dermatološki preparati - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.
lamivudine teva pharma b.v.
teva b.v. - lamivudin - okužbe z virusom hiv - antivirusi za sistemsko uporabo - lamivudin teva pharma b. je indiciran kot del protiretrovirusnega kombiniranega zdravljenja za zdravljenje odraslih in otrok, okuženih z virusom hiv in ljudi z virusom hiv.